Vanguard alumni aim to make high-quality cancer care more affordable, accessible, patient-centric.
30 actionable newsbits on capital raises, execs, pandemic and events, relocations and more.
New CEO charts rapid path toward 40 markets, says indie physician model both disruptive, scalable
Tracking moves among a baker's-dozen innovators, including Martin, McWhorter, Freeman, Johnson and more.
[Updated 3/15] 41 items, including SEC $ filings, tech talent, startups, entrepreneurial events, capital formation, exec roles, and more.
After eight years with Martin Ventures, Wilkinson joins portfolio company.
Converging activities could raise Nashville profile on global blockchain map.
[Updated] New entity focuses on "underserved" small and medium-sized businesses.
Rumors of a sale, new hand at Emma, Martin Ventures bet, and more.
[Updated] Blockchain initiatives now said to be expanding in Nashville.
International and national attendees gather in Nashville to focus on blockchain.
Healthcare entrepreneur believes status quo may be no more 'impregnable' than storied city's walls.
Maxwell, Bailey comment on technologies' interrelationship ahead of Oct. 3 event
Response to Brookings Institution researchers will require deep knowledge.
While talk of industry consolidation and impediments continues, entrepreneurs keep innovating.
Frank Coliano shares the view from one of Nashville's most interesting vantage-points.
[updated] Startup greenlighted with patient capital, golden Roladexes.
New CEO and founding chairman are apparently planning an aggressive push.
Education content and assessment are hot segments that Ingram seems to eye.
The rising tide of diabetes attracts investment to companies with convincing models
Luke Simons of Council Capital, Les Wilkinson of The Martin Companies and Si Deane's new sidebiz
Bottorff-, Gambill-led firm is amassing quite a healthcare brain trust
Shifts in command, marketing duties may add momentum in company now backed by entrepreneur with deepest pockets
At left, Denny Bottorff
Jacobson's new digs, Universal Robotics' placement, WSJ taps local analysts, Solidus' stake, antitrust cautions and more...
With $17.2 billion soon under the scalpel, startup feels it has a better mousetrap for improving quality and financial returns
There are no 'weathervanes' among these folks. Defining 'institutional', a caution about egos, and a reminder that sounds a lot like 'Dance with the one that brung ya'
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: